SR9011

Create: 12/18/2016

Expired Date:	12/18/2017
Category:	Raw materials [Health&Medical&Pharmaceutical]
Message:	SR9011 Product Name: SR9011 Molecular Formula: C23H31ClN4O3S Molecular Weight: 479.03524 Purity: 99% Grade: Pharmaceutical Grade Appearance: White Powder SR9011 is a research drug that was developed by Professor Thomas Burris of Scripps as an agonist of Rev-ErbAα with a half-maximum inhibitory concentration (IC50) = 790 nM for Rev-Erbα and IC50 = 560 nM for Rev-ErbAβ.






City:	Jinan Shandong[CN]
Location:

Dec 21 2016	CAS 593-51-1 Methylamine HCL	467
Dec 21 2016	CAS 83915-83-7 Lisinopril	475
Dec 21 2016	CAS 141922-90-9 Azasetron HCL	460
Dec 21 2016	CAS 15307-79-6 Diclofenac Sodium	462
Dec 21 2016	CAS 104987-11-3 Tacrolimus	476
Dec 21 2016	CAS 68-96-2 17alpha-Hydroxyprogesterone	486
Dec 21 2016	CAS 5534-09-8 Beclometasone Dipropionate	472
Dec 18 2016	SR9011	465
Dec 18 2016	CAS 118237-47-0 RAD-140	488
Dec 18 2016	CAS 1202044-20-9 MK-2866	462